This site uses Akismet to reduce spam. Learn how your comment data is processed.
Everyone is talking "recession" since the yield curve inversion last week – but that's not exactly right.
An inverted yield curve isn't always a bad thing for stocks. Typically in the month following this event, the market rises an average 1.5%. In the year after – 12%. So we're not running out of stocks right now.
Instead, we've found the best way to trade a rebound in a stock that got hit by the yield curve panic.
As our Fast Profits guest D.R. Barton, Jr., will show you, you can turn a stock's "pop" higher into a 100% gain when you know the right option to use.
The last time he gave us a trade like this, it delivered 60% in just two days. Another returned 478%.
Here's D.R. with this week's Fast Profits recommendation.
You just heard from D.R. on the post–yield curve inversion trade to make today. Here are the trade instructions:
Buy JPM April 18, 2019 $102 calls (JPM190418C00102000). Buy up to $1.20. Set up a stop loss to sell if options lose 55% of their value on a closing basis.D.R.'s Fast Profits recommendations have done exceptionally well. His last 12 winning Fast Profits trades have yielded total peak gains of 1,179.75%.
But you only get D.R.'s recommendations once a month, or less, with Fast Profits. Now you can get even more chances to make money with D.R. – big money – like potentially a $185,253 profit in the next eight days…
In fact, once you know how to use it (which he'll walk you through), you have the chance to turn a small stake into $1,000,000 or more in as little as 11 weeks.
Even better, you don't need any special training… any insider knowledge of the markets… or any exceptional skills to make it work for you.
Thousands of people have already put this strategy to work.
Don't waste another minute – click here to learn how you can join them today.
A Message to You from D.R. Barton, Jr.Hi, D.R. here.
As you just heard in my video above, there's nothing I love more than making money when a stock pops higher. And I love being able to turn a small stock gain into a big profit for you.
There's a secret to how I find these potentially lucrative trades…
In fact, I've found a way to do it in just MINUTES.
First, I spend hours scouring the market to identify these nearly invisible, "extreme" stock trends.
Then, I use my battle-tested technical trading program to analyze those extremes so I can tell my readers when I believe stock prices have been stretched too far. (Click here to learn how to get on my list.)
This system may be advanced, but it's not just for the professionals. In fact, anyone can use my approach to potentially create big profit "paychecks" almost every month for just a few minutes of work.
The best part is that it works in any market – bull, bear, or sideways – because you can profit from extremes in either direction.
And I can't wait to share it with you so you can identify these plays for yourself.
Click here to view my short presentation.
Follow Money Morning on Facebook and Twitter.
Join the conversation. Click here to jump to comments…
Why HBO CEO Richard Plepler is leaving after 27 years 6:57 AM ET Fri, 1 March 2019 | 09:18
Ionis Pharmaceuticals Inc (NASDAQ:IONS) Director B Lynne Parshall sold 8,334 shares of the firm’s stock in a transaction that occurred on Tuesday, March 12th. The shares were sold at an average price of $75.00, for a total transaction of $625,050.00. Following the completion of the transaction, the director now owns 61,011 shares of the company’s stock, valued at $4,575,825. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 
Brink’s (NYSE:BCO) CEO Douglas A. Pertz bought 5,000 shares of Brink’s stock in a transaction on Friday, March 8th. The stock was purchased at an average price of $72.65 per share, for a total transaction of $363,250.00. Following the completion of the acquisition, the chief executive officer now owns 251,900 shares in the company, valued at approximately $18,300,535. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 
Source: Shutterstock 
Tekla Capital Management LLC increased its holdings in shares of The Medicines Company (NASDAQ:MDCO) by 158.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 428,992 shares of the company’s stock after buying an additional 263,151 shares during the period. Tekla Capital Management LLC owned about 0.58% of The Medicines worth $8,211,000 at the end of the most recent quarter. 
AlphaCrest Capital Management LLC bought a new stake in shares of Illumina, Inc. (NASDAQ:ILMN) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 1,000 shares of the life sciences company’s stock, valued at approximately $300,000. 
Alambic Investment Management L.P. purchased a new stake in shares of PC Tel Inc (NASDAQ:PCTI) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 94,711 shares of the Wireless communications provider’s stock, valued at approximately $406,000. Alambic Investment Management L.P. owned approximately 0.52% of PC Tel at the end of the most recent reporting period.